http://www.aduro.com
Aduro Biotech, Inc. Company Intro
Aduro is a clinical-stage cancer immunotherapy company with multiple therapeutic approaches in development that have the potential to yield powerful immunotherapy combinations.
Industry
Healthcare
Aduro Biotech, Inc. Headquaters
740 Heinz Avenue
Berkeley,94710-2224
United States
Aduro Biotech, Inc. Share price
27 Oct 2020 01:01 GMT
$14.05
0.04 (0.29 %)
Aduro Biotech, Inc. Market cap
$236.611 M
WMC RANKING
2020
Aduro Biotech, Inc. # 114
BiotechnologyLatest Aduro Biotech, Inc. News
27 Oct 2020
Immuno-oncology Drugs Consumption Market Size 2020 By Product Types, End-Users, Regional Outlook, Growth, Trends And Forecast To 2027 | Market Research Intellect
Amgen; AstraZeneca; Plc; Bristol-Myers Squibb; Celgene Corporation; Eli Lilly ... Gilead Sciences Inc. Prometheus Therapeutics & Diagnostics; Aduro BioTech ...
27 Oct 2020
Immuno-oncology Drugs Market Segmentation By Qualitative ...
Eli Lilly and Company Merck & Co. Hoffmann-La Roche AG ... Gilead Sciences Inc. Prometheus Therapeutics & Diagnostics Aduro BioTech. Galena Biopharma
27 Oct 2020
Major Imact of COVID-19 outbreak on Vaccine, Insulin and ...
... Eli Lilly and Company, Glaxo SmithKline PLC, Geron Corporation., Ypsomed AG, Fate Therapeutics Inc., INC., Aduro biotech, ImmunoCellular Therapeutics ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Aduro Biotech, Inc. | 0.49 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.31 | 100 | 20 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.32 | 26 | 0 | 0 | 97.51 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 2.78 |
| Incyte Corporation | 40.27 | 14.26 | 7.19 | 100 | 0 | 0 | 90.89 |
Aduro Biotech, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Aduro Biotech, Inc. | $27,270 | $100,319 | $-66,520 | $236.611M | 114 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.467B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $53.956B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.394B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.779B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Aduro Biotech, Inc. Social Followers vs Top 4 Industry Competitors
Aduro Biotech, Inc. Post vs Top 4 Industry Competitors
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
